Tag: venture capital

The virus killer we need – from Nitric Oxide: SaNOtize

0 commentsUncategorizedantimicrobialcoronavirusCOVIDCOVID19Daily Dosehand sanitizerJon Medvednitric oxideOurCrowdSaNOtizestartup investingstartupstechnologyventure capitalvirus

OurCrowd CEO, Jon Medved, talks about the importance of washing hands and social distancing in the fight to prevent infection. One of our portfolio companies SaNOtize led by Dr. Gilly Regev and Dr. Chris Miller, is working on a virus killer to keep medial professionals safe throughout the day. With the use of Nitric Oxide, they created a three pronged set of products including a mouthwash for the morning, nasal spray during the day and ….  Read More